Celltrion Opens Up Canadian Market For Remsima SC

Launches Subcutaneous Version Of Biosimilar Infliximab Rival To Remicade

Canada Flag Open Door
Celltrion’s launch opens up the Canadian market for Remsima SC • Source: Alamy

More from Biosimilars

More from Products